Todavía no hay suficientes señales de compra con un horizonte T+90 consolidado para medir un historial.
Historial de señales
Browse the full record of transactions filed by Schneyer Mark C., Director Financiero. Director active across 1 company, notably Acadia Pharmaceuticals INC. In total, 45 filings have been published. Breakdown: 0 buy · 17 sells. Total volume traded: €2m. Activity tracked since 23 February 2022. The latest transaction was filed on 6 August 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Schneyer Mark C.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9733 títulos@ 15,28 US$8.9% de su flujoCommon StockSEC:0001415889-24-021731:2
25 de 45 declaraciones
About Schneyer Mark C.
Schneyer Mark C. is Directeur Financier at Acadia Pharmaceuticals INC, where he is EVP, CHIEF FINANCIAL OFFICER. He has 40 filings in total, and in the most recent filings available there were only sales for a total of EUR 1502572, over the period from 2022-02-25 to 2026-05-05.